Cisplatin, cisplatinum or cis-diamminedichloroplatinum(II) (CDDP) is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas and germ cell tumors. It was the first member of its class, which now also includes carboplatin and oxaliplatin.
For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer.
University of Cincinnati Medical Center, Cincinnati, Ohio, United States
Clinical Trials Nurse Navigator, Scottsdale, Arizona, United States
The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Haga, Den Haag, Netherlands
Spaarne Gasthuis, Hoofddorp, Netherlands
Medisch Centrum Leeuwarden, Leeuwarden, Netherlands
Bristol Haematology & Oncology, Bristol, United Kingdom
Aberdeen Royal Infirmary, Aberdeen, United Kingdom
Velindre Cancer Care Centre, Cardiff, United Kingdom
CHU Dijon, Dijon, France
CHRU de Lille - Hôpital Claude Huriez, Lille, France
Institut Jules Bordet, Bruxelles, Belgium
IU Health North Hospital, Carmel, Indiana, United States
UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States
Sanford Broadway Medical Center, Fargo, North Dakota, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.